PNC Financial Services Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,095
| Closed | -$252 | – | 5029 |
|
|
2024
Q4 | $252 | Hold |
1,095
| – | – | ﹤0.01% | 4624 |
|
|
2024
Q3 | $2.35K | Hold |
1,095
| – | – | ﹤0.01% | 4259 |
|
|
2024
Q2 | $5.65K | Hold |
1,095
| – | – | ﹤0.01% | 3957 |
|
|
2024
Q1 | $5.86K | Hold |
1,095
| – | – | ﹤0.01% | 3913 |
|
|
2023
Q4 | $8.53K | Hold |
1,095
| – | – | ﹤0.01% | 3784 |
|
|
2023
Q3 | $4.33K | Hold |
1,095
| – | – | ﹤0.01% | 4026 |
|
|
2023
Q2 | $3.45K | Hold |
1,095
| – | – | ﹤0.01% | 4212 |
|
|
2023
Q1 | $2.92K | Hold |
1,095
| – | – | ﹤0.01% | 4209 |
|
|
2022
Q4 | $3.93K | Hold |
1,095
| – | – | ﹤0.01% | 4068 |
|
|
2022
Q3 | $7K | Buy |
+1,095
| New | +$7K | ﹤0.01% | 3893 |
|